img

Global Genito-Urinary Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Genito-Urinary Drugs Market Insights, Forecast to 2034

Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
Global Genito-Urinary Drugs market is expected to reach to US$ 29570 million in 2024, with a positive growth of %, compared with US$ 28510 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Genito-Urinary Drugs industry is evaluated to reach US$ 35930 million in 2029. The CAGR will be 3.3% during 2024 to 2029.
The Genito-Urinary Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders and diseases related to the genitourinary system, which includes the reproductive organs and the urinary tract. This market encompasses various therapeutic areas such as erectile dysfunction, urinary incontinence, urinary tract infections, and prostate disorders. The Genito-Urinary Drugs market has been witnessing steady growth in recent years due to factors such as the increasing prevalence of genitourinary disorders, rising awareness about available treatment options, and advancements in drug development. Additionally, the aging population and changing lifestyle patterns have contributed to the market's expansion.
Report Covers
This report presents an overview of global Genito-Urinary Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Genito-Urinary Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
AbbVie
GSK
Otsuka Pharmaceutical
Sanofi
Segment by Type
OTC
Rx Drugs

Segment by Application


Hospital
Drugs Store
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Genito-Urinary Drugs plant distribution, commercial date of Genito-Urinary Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Genito-Urinary Drugs introduction, etc. Genito-Urinary Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Genito-Urinary Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Genito-Urinary Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Genito-Urinary Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Genito-Urinary Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Genito-Urinary Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Genito-Urinary Drugs Revenue by Region
2.2.1 Global Genito-Urinary Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Genito-Urinary Drugs Revenue by Region (2018-2024)
2.2.3 Global Genito-Urinary Drugs Revenue by Region (2024-2029)
2.2.4 Global Genito-Urinary Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Genito-Urinary Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Genito-Urinary Drugs Sales by Region
2.4.1 Global Genito-Urinary Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Genito-Urinary Drugs Sales by Region (2018-2024)
2.4.3 Global Genito-Urinary Drugs Sales by Region (2024-2029)
2.4.4 Global Genito-Urinary Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Genito-Urinary Drugs Sales by Manufacturers
3.1.1 Global Genito-Urinary Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Genito-Urinary Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genito-Urinary Drugs in 2022
3.2 Global Genito-Urinary Drugs Revenue by Manufacturers
3.2.1 Global Genito-Urinary Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Genito-Urinary Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Genito-Urinary Drugs Revenue in 2022
3.3 Global Key Players of Genito-Urinary Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Genito-Urinary Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Genito-Urinary Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Genito-Urinary Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Genito-Urinary Drugs Sales by Type
4.1.1 Global Genito-Urinary Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Genito-Urinary Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
4.2 Global Genito-Urinary Drugs Revenue by Type
4.2.1 Global Genito-Urinary Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Genito-Urinary Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Genito-Urinary Drugs Price by Type
4.3.1 Global Genito-Urinary Drugs Price by Type (2018-2024)
4.3.2 Global Genito-Urinary Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Genito-Urinary Drugs Sales by Application
5.1.1 Global Genito-Urinary Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Genito-Urinary Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
5.2 Global Genito-Urinary Drugs Revenue by Application
5.2.1 Global Genito-Urinary Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Genito-Urinary Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Genito-Urinary Drugs Price by Application
5.3.1 Global Genito-Urinary Drugs Price by Application (2018-2024)
5.3.2 Global Genito-Urinary Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Genito-Urinary Drugs Market Size by Type
6.1.1 US & Canada Genito-Urinary Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Genito-Urinary Drugs Revenue by Type (2018-2029)
6.2 US & Canada Genito-Urinary Drugs Market Size by Application
6.2.1 US & Canada Genito-Urinary Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Genito-Urinary Drugs Revenue by Application (2018-2029)
6.3 US & Canada Genito-Urinary Drugs Market Size by Country
6.3.1 US & Canada Genito-Urinary Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Genito-Urinary Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Genito-Urinary Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Genito-Urinary Drugs Market Size by Type
7.1.1 Europe Genito-Urinary Drugs Sales by Type (2018-2029)
7.1.2 Europe Genito-Urinary Drugs Revenue by Type (2018-2029)
7.2 Europe Genito-Urinary Drugs Market Size by Application
7.2.1 Europe Genito-Urinary Drugs Sales by Application (2018-2029)
7.2.2 Europe Genito-Urinary Drugs Revenue by Application (2018-2029)
7.3 Europe Genito-Urinary Drugs Market Size by Country
7.3.1 Europe Genito-Urinary Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Genito-Urinary Drugs Sales by Country (2018-2029)
7.3.3 Europe Genito-Urinary Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Genito-Urinary Drugs Market Size
8.1.1 China Genito-Urinary Drugs Sales (2018-2029)
8.1.2 China Genito-Urinary Drugs Revenue (2018-2029)
8.2 China Genito-Urinary Drugs Market Size by Application
8.2.1 China Genito-Urinary Drugs Sales by Application (2018-2029)
8.2.2 China Genito-Urinary Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Genito-Urinary Drugs Market Size by Type
9.1.1 Asia Genito-Urinary Drugs Sales by Type (2018-2029)
9.1.2 Asia Genito-Urinary Drugs Revenue by Type (2018-2029)
9.2 Asia Genito-Urinary Drugs Market Size by Application
9.2.1 Asia Genito-Urinary Drugs Sales by Application (2018-2029)
9.2.2 Asia Genito-Urinary Drugs Revenue by Application (2018-2029)
9.3 Asia Genito-Urinary Drugs Sales by Region
9.3.1 Asia Genito-Urinary Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Genito-Urinary Drugs Revenue by Region (2018-2029)
9.3.3 Asia Genito-Urinary Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Genito-Urinary Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Genito-Urinary Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Information
11.1.2 Daiichi Sankyo Company Overview
11.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Daiichi Sankyo Company Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Overview
11.3.3 Bayer Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bayer Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Information
11.4.2 Astellas Pharma Overview
11.4.3 Astellas Pharma Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Astellas Pharma Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astellas Pharma Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AbbVie Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AbbVie Recent Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Overview
11.6.3 GSK Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GSK Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Information
11.7.2 Otsuka Pharmaceutical Overview
11.7.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Otsuka Pharmaceutical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Genito-Urinary Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sanofi Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Genito-Urinary Drugs Industry Chain Analysis
12.2 Genito-Urinary Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genito-Urinary Drugs Production Mode & Process
12.4 Genito-Urinary Drugs Sales and Marketing
12.4.1 Genito-Urinary Drugs Sales Channels
12.4.2 Genito-Urinary Drugs Distributors
12.5 Genito-Urinary Drugs Customers
13 Market Dynamics
13.1 Genito-Urinary Drugs Industry Trends
13.2 Genito-Urinary Drugs Market Drivers
13.3 Genito-Urinary Drugs Market Challenges
13.4 Genito-Urinary Drugs Market Restraints
14 Key Findings in The Global Genito-Urinary Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Genito-Urinary Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of OTC
Table 3. Major Manufacturers of Rx Drugs
Table 4. Global Genito-Urinary Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Genito-Urinary Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Genito-Urinary Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Genito-Urinary Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Genito-Urinary Drugs Revenue Market Share by Region (2018-2024)
Table 9. Global Genito-Urinary Drugs Revenue Market Share by Region (2024-2029)
Table 10. Global Genito-Urinary Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Genito-Urinary Drugs Sales by Region (2018-2024) & (K Units)
Table 12. Global Genito-Urinary Drugs Sales by Region (2024-2029) & (K Units)
Table 13. Global Genito-Urinary Drugs Sales Market Share by Region (2018-2024)
Table 14. Global Genito-Urinary Drugs Sales Market Share by Region (2024-2029)
Table 15. Global Genito-Urinary Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Genito-Urinary Drugs Sales Share by Manufacturers (2018-2024)
Table 17. Global Genito-Urinary Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Genito-Urinary Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Genito-Urinary Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Genito-Urinary Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Genito-Urinary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Genito-Urinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genito-Urinary Drugs as of 2022)
Table 23. Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Genito-Urinary Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Genito-Urinary Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genito-Urinary Drugs Sales by Type (2018-2024) & (K Units)
Table 28. Global Genito-Urinary Drugs Sales by Type (2024-2029) & (K Units)
Table 29. Global Genito-Urinary Drugs Sales Share by Type (2018-2024)
Table 30. Global Genito-Urinary Drugs Sales Share by Type (2024-2029)
Table 31. Global Genito-Urinary Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Genito-Urinary Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Genito-Urinary Drugs Revenue Share by Type (2018-2024)
Table 34. Global Genito-Urinary Drugs Revenue Share by Type (2024-2029)
Table 35. Genito-Urinary Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Genito-Urinary Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Genito-Urinary Drugs Sales by Application (2018-2024) & (K Units)
Table 38. Global Genito-Urinary Drugs Sales by Application (2024-2029) & (K Units)
Table 39. Global Genito-Urinary Drugs Sales Share by Application (2018-2024)
Table 40. Global Genito-Urinary Drugs Sales Share by Application (2024-2029)
Table 41. Global Genito-Urinary Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Genito-Urinary Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Genito-Urinary Drugs Revenue Share by Application (2018-2024)
Table 44. Global Genito-Urinary Drugs Revenue Share by Application (2024-2029)
Table 45. Genito-Urinary Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Genito-Urinary Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Genito-Urinary Drugs Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Genito-Urinary Drugs Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Genito-Urinary Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Genito-Urinary Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Genito-Urinary Drugs Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Genito-Urinary Drugs Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Genito-Urinary Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Genito-Urinary Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Genito-Urinary Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Genito-Urinary Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Genito-Urinary Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Genito-Urinary Drugs Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Genito-Urinary Drugs Sales by Country (2024-2029) & (K Units)
Table 60. Europe Genito-Urinary Drugs Sales by Type (2018-2024) & (K Units)
Table 61. Europe Genito-Urinary Drugs Sales by Type (2024-2029) & (K Units)
Table 62. Europe Genito-Urinary Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Genito-Urinary Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Genito-Urinary Drugs Sales by Application (2018-2024) & (K Units)
Table 65. Europe Genito-Urinary Drugs Sales by Application (2024-2029) & (K Units)
Table 66. Europe Genito-Urinary Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Genito-Urinary Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Genito-Urinary Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Genito-Urinary Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Genito-Urinary Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Genito-Urinary Drugs Sales by Country (2018-2024) & (K Units)
Table 72. Europe Genito-Urinary Drugs Sales by Country (2024-2029) & (K Units)
Table 73. China Genito-Urinary Drugs Sales by Type (2018-2024) & (K Units)
Table 74. China Genito-Urinary Drugs Sales by Type (2024-2029) & (K Units)
Table 75. China Genito-Urinary Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Genito-Urinary Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Genito-Urinary Drugs Sales by Application (2018-2024) & (K Units)
Table 78. China Genito-Urinary Drugs Sales by Application (2024-2029) & (K Units)
Table 79. China Genito-Urinary Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Genito-Urinary Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Genito-Urinary Drugs Sales by Type (2018-2024) & (K Units)
Table 82. Asia Genito-Urinary Drugs Sales by Type (2024-2029) & (K Units)
Table 83. Asia Genito-Urinary Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Genito-Urinary Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Genito-Urinary Drugs Sales by Application (2018-2024) & (K Units)
Table 86. Asia Genito-Urinary Drugs Sales by Application (2024-2029) & (K Units)
Table 87. Asia Genito-Urinary Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Genito-Urinary Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Genito-Urinary Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Genito-Urinary Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Genito-Urinary Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Genito-Urinary Drugs Sales by Region (2018-2024) & (K Units)
Table 93. Asia Genito-Urinary Drugs Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Genito-Urinary Drugs Sales by Country (2024-2029) & (K Units)
Table 107. Daiichi Sankyo Company Company Information
Table 108. Daiichi Sankyo Company Description and Major Businesses
Table 109. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Daiichi Sankyo Company Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Daiichi Sankyo Company Recent Developments
Table 112. Pfizer Company Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Pfizer Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Developments
Table 117. Bayer Company Information
Table 118. Bayer Description and Major Businesses
Table 119. Bayer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Bayer Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bayer Recent Developments
Table 122. Astellas Pharma Company Information
Table 123. Astellas Pharma Description and Major Businesses
Table 124. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Astellas Pharma Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Astellas Pharma Recent Developments
Table 127. AbbVie Company Information
Table 128. AbbVie Description and Major Businesses
Table 129. AbbVie Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. AbbVie Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AbbVie Recent Developments
Table 132. GSK Company Information
Table 133. GSK Description and Major Businesses
Table 134. GSK Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. GSK Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GSK Recent Developments
Table 137. Otsuka Pharmaceutical Company Information
Table 138. Otsuka Pharmaceutical Description and Major Businesses
Table 139. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Otsuka Pharmaceutical Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Otsuka Pharmaceutical Recent Developments
Table 142. Sanofi Company Information
Table 143. Sanofi Description and Major Businesses
Table 144. Sanofi Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Sanofi Genito-Urinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sanofi Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Genito-Urinary Drugs Distributors List
Table 150. Genito-Urinary Drugs Customers List
Table 151. Genito-Urinary Drugs Market Trends
Table 152. Genito-Urinary Drugs Market Drivers
Table 153. Genito-Urinary Drugs Market Challenges
Table 154. Genito-Urinary Drugs Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Genito-Urinary Drugs Product Picture
Figure 2. Global Genito-Urinary Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Genito-Urinary Drugs Market Share by Type in 2022 & 2029
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Genito-Urinary Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Genito-Urinary Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Other
Figure 11. Genito-Urinary Drugs Report Years Considered
Figure 12. Global Genito-Urinary Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Genito-Urinary Drugs Revenue 2018-2029 (US$ Million)
Figure 14. Global Genito-Urinary Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Genito-Urinary Drugs Revenue Market Share by Region (2018-2029)
Figure 16. Global Genito-Urinary Drugs Sales 2018-2029 ((K Units)
Figure 17. Global Genito-Urinary Drugs Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Genito-Urinary Drugs Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Genito-Urinary Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Genito-Urinary Drugs Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Genito-Urinary Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Genito-Urinary Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. China Genito-Urinary Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Genito-Urinary Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Genito-Urinary Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Genito-Urinary Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Genito-Urinary Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Genito-Urinary Drugs in the World: Market Share by Genito-Urinary Drugs Revenue in 2022
Figure 30. Global Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
Figure 32. Global Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
Figure 33. Global Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
Figure 34. Global Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Genito-Urinary Drugs Revenue Share by Country (2018-2029)
Figure 40. US & Canada Genito-Urinary Drugs Sales Share by Country (2018-2029)
Figure 41. U.S. Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
Figure 44. Europe Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
Figure 45. Europe Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
Figure 46. Europe Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
Figure 47. Europe Genito-Urinary Drugs Revenue Share by Country (2018-2029)
Figure 48. Europe Genito-Urinary Drugs Sales Share by Country (2018-2029)
Figure 49. Germany Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. France Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. UK Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. China Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
Figure 55. China Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
Figure 56. China Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
Figure 57. China Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
Figure 58. Asia Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
Figure 59. Asia Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
Figure 60. Asia Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
Figure 61. Asia Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Genito-Urinary Drugs Revenue Share by Region (2018-2029)
Figure 63. Asia Genito-Urinary Drugs Sales Share by Region (2018-2029)
Figure 64. Japan Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. India Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Genito-Urinary Drugs Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Genito-Urinary Drugs Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Genito-Urinary Drugs Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Genito-Urinary Drugs Sales Share by Country (2018-2029)
Figure 75. Brazil Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Genito-Urinary Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Genito-Urinary Drugs Value Chain
Figure 81. Genito-Urinary Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed